Shahla Eyvari Brooshghalan

Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular study

Rasool Haddadi, Alireza Mohajjel Nayebi, Safar Farajniya et al. · DARU Journal of Pharmaceutical Sciences · 2014 · 51 citations · Full text

Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats

Rasool Haddadi, Alireza Mohajjel Nayebi, Shahla Eyvari Brooshghalan · Neuroscience Letters · 2013 · 39 citations

Inflammation, Inflammatory Cytokines, 6-Ohda Hemi-parkinsonian Rats +12

RETRACTED: Silymarin prevents apoptosis through inhibiting the Bax/caspase-3 expression and suppresses toll like receptor-4 pathway in the SNc of 6-OHDA intoxicated rats

Rasool Haddadi, Alireza Mohajjel Nayebi, Shahla Eyvari Brooshghalan · Biomedicine & Pharmacotherapy · 2018 · 39 citations

Inflammation, Receptor-4 Pathway, Autoimmune Disease +12

Short-Term Treatment with Silymarin Improved 6-OHDA-Induced Catalepsy and Motor Imbalance in Hemi-Parkisonian Rats

Rasool Haddadi, Shahla Eyvari Brooshghalan, Safar Farajniya et al. · Advanced Pharmaceutical Bulletin · 2015 · 22 citations · Full text

Silibinin chronic treatment in a rat model of Parkinson disease: A comprehensive in-vivo evaluation and in silico molecular modeling

Shahla Eyvari Brooshghalan, Mohammadmahdi Sabahi, Ahmad Ebadi et al. · European Journal of Pharmacology · 2023 · 10 citations